English
Home > Products > CAS NO 528-58-5

China CAS NO 528-58-5 Factory

Being a result of ours specialty and service consciousness, our corporation has won a very good status amid buyers all over the world for CAS NO 528-58-5,528-58-5,Cyanidin chloride, Sincerely stay up for serving you from the in the vicinity of future. You are sincerely welcome to go to our company to talk company face to face with each other and create long-term co-operation with us!
CAS NO 528-58-5, Now, with the development of internet, and the trend of internationalization, we've got decided to extend business to overseas market. With the propose of bringing more profits to oversea customers by providing directly abroad. So we have changed our mind, from home to abroad, hope to give our customers more profit, and looking forward to more chance to make business.

Related Products

Hot Products

  • Oclacitinib maleate

    Oclacitinib maleate

    Product Name:Oclacitinib maleate
    Molecular Formula:C19H27N5O6S
    Molecular Weight;453.51258
    CAS Registry Number;1640292-55-2
  • Lafutidine

    Lafutidine

    Product Name:Lafutidine
    Molecular Formula:C22H29N3O4S
    Molecular Weight;431.55
    CAS Registry Number;118288-08-7
  • 2,4-Difluorobenzyl chloride

    2,4-Difluorobenzyl chloride

    Product Name:2,4-Difluorobenzyl chloride
    Molecular Formula:C7H5ClF2
    Molecular Weight:162.56
    CAS Registry Number:452-07-3
  • Lanreotide Acetate

    Lanreotide Acetate

    Product Name:Lanreotide Acetate
    Molecular Formula:C54H69N11O10S2
    Molecular Weight;1096.326
    CAS Registry Number;127984-74-1
  • (2S,3R)-Methyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate

    (2S,3R)-Methyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate

    Product Name:(2S,3R)-Methyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate
    Molecular Formula:C15H21NO5
    Molecular Weight:295.34
    CAS Registry Number:161759-90-6
  • 2-Fluorobenzyl alcohol

    2-Fluorobenzyl alcohol

    Product Name:2-Fluorobenzyl alcohol
    Molecular Formula:C7H7FO
    Molecular Weight:126.13
    CAS Registry Number:446-51-5
  • Related Blog
  • Reviews

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept